This is not the most recent version of the article. View current version (17 OCT 2012)

Intervention Protocol

High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma

  1. A Greb,
  2. J Bohlius,
  3. B Djulbegovic,
  4. K Wheatley,
  5. T Kober,
  6. A Engert

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 20 OCT 2003

DOI: 10.1002/14651858.CD004626


How to Cite

Greb A, Bohlius J, Djulbegovic B, Wheatley K, Kober T, Engert A. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma (Protocol). Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD004626. DOI: 10.1002/14651858.CD004626.

Author Information

*Dr Alexander Greb, Carl-Schurz Str 8, Cologne, 50935, GERMANY. alexandergreb@freenet.de.

Publication History

  1. Published Online: 20 OCT 2003

SEARCH

This is not the most recent version of the article. View current version (17 OCT 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review consists of two comparisons, which are to be analysed separately:

(I) To determine whether high-dose chemotherapy and autologous stem cell transplantation is more effective than conventional chemotherapy for patients with multiple myeloma,
and
(II) to determine whether tandem high-dose chemotherapy and autologous stem cell transplantation is more effective than single high-dose chemotherapy and autologous stem cell transplantation for patients with multiple myeloma.